Search results
Mainz Biomed Provides Half Year 2024 Corporate Update
PharmiWeb· 2 days agoMAINZ, Germany – July 2, 2024 — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments ...